The Laboratory tubes

Product

Hot New Products Alpha-Lipoic Acid 1077-28-7 - Mitomycin C 50-07-7 Antibiotic Antineoplastic – Neore

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

With this motto in mind, we've come to be one of quite possibly the most technologically innovative, cost-efficient, and price-competitive manufacturers for 117704-25-3, 56-25-7, 112828-00-9, We usually concertrating on acquiring new creative products to fulfill request from our clientele all around the world. Be a part of us and let's make driving safer and funnier jointly!
Hot New Products Alpha-Lipoic Acid 1077-28-7 - Mitomycin C 50-07-7 Antibiotic Antineoplastic – Neore Detail:

Payment: T/T, L/C
Product Origin: China
Shipping Port: Beijing/Shanghai/Hangzhou
Production capacity: 5kg/month
Order(MOQ): 10g
Lead Time: 3 Working Days
Storage condition: Stored in cool, dry place, room temperature.
Package material: vial
Package size: 10g/drum
Safety information:  UN 2811 6.1/ PG 1

Mitomycin C

Description

Mitomycin C is a mitomycin that is used as a chemotherapeutic agent by virtue of its antitumour activity.

It is given intravenously to treat upper gastro-intestinal cancers (e.g. esophageal carcinoma), anal cancers, and breast cancers, as well as by bladder instillation for superficial bladder tumours.

Mitomycin C is used in cancers, particularly bladder cancers and intraperitoneal tumours.

Mitomycin C is used in eye surgery where mitomycin C 0.02% is applied topically to prevent scarring during glaucoma filtering surgery and to prevent haze after PRK or LASIK; mitomycin C has also been shown to reduce fibrosis in strabismus surgery.

Mitomycin C is used in esophageal and tracheal stenosis where application of mitomycin C onto the mucosa immediately following dilatation will decrease re-stenosis by decreasing the production of fibroblasts and scar tissue.

Specification (USP/EP)

Item

Specification

Appearance

Blue-violet, crystalline powder

Identification

IR: The IR spectrum of the sample corresponds to the spectrum of reference standard
  HPLC: The retention time of the major peak of the sample solution corresponds to that of the standard solution, as obtained in the Assay
pH

6.0~7.5

Water

Not more than 2.5%

Crystallinity

Should conforms

Related Substances
Albomitomycin C

(EP Impurity D)

Not more than 0.5%

Mitomycin B

(EP Impurity C)

Not more than 0.5%

Cinnamamide

(EP Impurity A)

Not more than 0.5%

Mitomycin A

(EP Impurity B)

Not more than 0.5%

Any Individual Unspecified Impurity

Not more than 0.5%

Total Impurities

Not more than 2.0%

Residual Solvents
Methanol

Not more than 3000 ppm

Methylene Chloride

Not more than 600 ppm

Ethyl Acetate

Not more than 5000 ppm

Bacterial Endotoxins

Not more than 10 EU/mg

Assay

Not less than 970 mg/g of Mitomycin


Product detail pictures:

Hot New Products Alpha-Lipoic Acid 1077-28-7 - Mitomycin C 50-07-7 Antibiotic Antineoplastic – Neore detail pictures


Related Product Guide:

Quality First,and Customer Supreme is our guideline to provide the best service to our customers.Nowadays, we are trying our best to become one of the best exporters in our field to meet customers more need for Hot New Products Alpha-Lipoic Acid 1077-28-7 - Mitomycin C 50-07-7 Antibiotic Antineoplastic – Neore , The product will supply to all over the world, such as: Indonesia, European, Bahrain, Taking the core concept of "to be the Responsible". We will redound up on society for high quality products and good service. We will initiative to participate in international competition to be a first- class manufacturer of this product in the world.
  • High production efficiency and good product quality, fast delivery and completed after-sale protection, a right choice, a best choice.
    5 Stars By Danny from Iraq - 2018.06.05 13:10
    This company has the idea of "better quality, lower processing costs, prices are more reasonable", so they have competitive product quality and price, that's the main reason we chose to cooperate.
    5 Stars By Fanny from Korea - 2018.12.28 15:18